Takeda Pharmaceutical (TAK) Non-Current Assets: 2018-2025

Historic Non-Current Assets for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $77.0 billion.

  • Takeda Pharmaceutical's Non-Current Assets fell 9.23% to $76.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $76.9 billion, marking a year-over-year decrease of 9.23%. This contributed to the annual value of $77.0 billion for FY2025, which is 11.53% down from last year.
  • As of FY2025, Takeda Pharmaceutical's Non-Current Assets stood at $77.0 billion, which was down 11.53% from $87.0 billion recorded in FY2024.
  • Takeda Pharmaceutical's Non-Current Assets' 5-year high stood at $96.2 billion during FY2021, with a 5-year trough of $77.0 billion in FY2025.
  • Moreover, its 3-year median value for Non-Current Assets was $85.6 billion (2023), whereas its average is $83.2 billion.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Non-Current Assets climbed by 1.70% in 2024, and later dropped by 11.53% in 2025.
  • Yearly analysis of 5 years shows Takeda Pharmaceutical's Non-Current Assets stood at $96.2 billion in 2021, then fell by 2.01% to $94.3 billion in 2022, then dropped by 9.24% to $85.6 billion in 2023, then rose by 1.70% to $87.0 billion in 2024, then decreased by 11.53% to $77.0 billion in 2025.